SNCA and Alzheimer disease: Studies show that α-synuclein may actually be relevant in discriminating AD from DLB, but the changes do not come from DLB patients (not significantly different from controls), but from AD patients with higher levels of α-synuclein in the CSF of AD patients compared to DLB and control patients [19,20,21].